Drawing for AIMM

USPTO serial 99486742

AIMM

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
ALLEN, BIANCA LEIGH
Law office
TMO LAW OFFICE 123

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AIMM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Duan Wu

Duan Wu MILSTEIN ZHANG & WU LLC2000 Commonwealth AveSte 400Newton, MA 02466

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Dietetic preparations adapted for medical purposes; Dietetic supplements adapted for medical purposes; Vitamin and mineral supplements; Vitamin and mineral preparations for medical use; Powdered nutritional supplement drink mix containing proteins, vitamins, and minerals; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases, rheumatic diseases, bone diseases, digestive diseases, cancers and complications thereofACTIVE—
035Advertising services in the field of medical products and their research and development, pharmaceuticals and their research and development; Business consulting, management, and planning services in the field of medical product research and development, pharmaceutical research and development; Online advertising and marketing services in the field of medical, medical product and pharmaceutical research and developmentACTIVE—
042Scientific and technological services, namely, research and development in the field of medicine, medical products, and pharmaceuticals; Scientific and technological services, namely, research and design in the field of medicine, biological and life sciencesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 24, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 24, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jul 24, 2026CNSLSUSPENSION LETTER WRITTEN—
Jun 26, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 25, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 25, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2026DOCKASSIGNED TO EXAMINER—
Feb 13, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 9, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 9, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance